{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:20:11Z","timestamp":1792095611779,"version":"4.4.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS113969-01"],"award-info":[{"award-number":["R01NS113969-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1RF1NS125578-01"],"award-info":[{"award-number":["1RF1NS125578-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","award":["21A13"],"award-info":[{"award-number":["21A13"]}],"id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.trsl.2022.08.014","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T21:02:52Z","timestamp":1662411772000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Inflammasome activation in traumatic brain injury and Alzheimer's disease"],"prefix":"10.1016","volume":"254","author":[{"given":"Nathan H.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"de Rivero Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Bramlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-4942","authenticated-orcid":false,"given":"W. Dalton","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2022.08.014_bib0001","first-page":"1","article-title":"Surveillance for traumatic brain injury-related deaths\u2013United States, 1997-2007","volume":"60","author":"Coronado","year":"2011","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.trsl.2022.08.014_bib0002","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1682\/JRRD.2006.05.0054","article-title":"Persistent problems after traumatic brain injury: the need for long-term follow-up and coordinated care","volume":"43","author":"Lew","year":"2006","journal-title":"J Rehabil Res Dev"},{"key":"10.1016\/j.trsl.2022.08.014_bib0003","series-title":"Surveillance report of traumatic brain injury-related hospitalizations and deaths by age group, sex, and mechanism of injury\u2014United States, 2016 and 2017","year":"2021"},{"key":"10.1016\/j.trsl.2022.08.014_bib0004","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/HTR.0000000000000067","article-title":"Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome at 6 and 12 months postinjury","volume":"30","author":"Kumar","year":"2015","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.trsl.2022.08.014_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113080","article-title":"Neural-respiratory inflammasome axis in traumatic brain injury","volume":"323","author":"Kerr","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0006","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1089\/neu.2017.5430","article-title":"Traumatic brain injury-induced acute lung injury: evidence for activation and inhibition of a neural-respiratory-inflammasome axis","volume":"35","author":"Kerr","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0007","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/neu.2020.7257","article-title":"Enoxaparin attenuates acute lung injury and inflammasome activation after traumatic brain injury","volume":"38","author":"Kerr","year":"2021","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0008","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3233\/JAD-190572","article-title":"Long-term effects of traumatic brain injury in a mouse model of Alzheimer's disease","volume":"72","author":"Zysk","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.trsl.2022.08.014_bib0009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.570711","article-title":"The role of microglia and the nlrp3 inflammasome in Alzheimer's disease","volume":"11","author":"Hanslik","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0011","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12974-019-1423-6","article-title":"The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury","volume":"16","author":"Lee","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trsl.2022.08.014_bib0012","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.08.014_bib0014","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.08.014_bib0015","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1089\/neu.2017.5530","article-title":"Microglial inflammasome activation in penetrating ballistic-like brain injury","volume":"35","author":"Lee","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223180","article-title":"Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury","volume":"14","author":"Titus","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2022.08.014_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/neu.2017.5103","article-title":"The impact of traumatic brain injury on later life: effects on normal aging and neurodegenerative diseases","volume":"35","author":"Griesbach","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0018","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1089\/neu.2014.3352","article-title":"Long-term consequences of traumatic brain injury: current status of potential mechanisms of injury and neurological outcomes","volume":"32","author":"Bramlett","year":"2015","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0019","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.metabol.2017.01.014","article-title":"Alzheimer's disease: innate immunity gone awry?","author":"VanItallie","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2022.08.014_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0021","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/jcbfm.2008.143","article-title":"Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice","volume":"29","author":"Abulafia","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.trsl.2022.08.014_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.774014","article-title":"The role of non-canonical and canonical inflammasomes in inflammaging","volume":"15","author":"Cyr","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0023","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2009.46","article-title":"Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury","volume":"29","author":"de Rivero Vaccari","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.trsl.2022.08.014_bib0024","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1523\/JNEUROSCI.0157-08.2008","article-title":"A molecular platform in neurons regulates inflammation after spinal cord injury","volume":"28","author":"de Rivero Vaccari","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/glia.22499","article-title":"Human astrocytes express a novel NLRP2 inflammasome","volume":"61","author":"Minkiewicz","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.trsl.2022.08.014_bib0026","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/dneu.22409","article-title":"High glucocorticoid levels during gestation activate the inflammasome in hippocampal oligodendrocytes of the offspring","volume":"77","author":"Maturana","year":"2017","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0027","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1038\/srep04422","article-title":"Immune privilege of the CNS is not the consequence of limited antigen sampling","volume":"4","author":"Harris","year":"2014","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.trsl.2022.08.014_bib0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/imr.13126","article-title":"Neuroimmune signaling at the brain borders","volume":"311","author":"Frederick","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2022.08.014_bib0029","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.it.2021.04.003","article-title":"Neuroimmune cleanup crews in brain injury","volume":"42","author":"Bolte","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-immunol-093019-110159","article-title":"Microglia and central nervous system-associated macrophages-from origin to disease modulation","volume":"39","author":"Prinz","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0031","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/brv.12797","article-title":"Plasticity of microglia","volume":"97","author":"Augusto-Oliveira","year":"2022","journal-title":"Biol Rev Camb Philos Soc"},{"key":"10.1016\/j.trsl.2022.08.014_bib0032","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-11-12","article-title":"Morphometric characterization of microglial phenotypes in human cerebral cortex","volume":"11","author":"Torres-Platas","year":"2014","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.trsl.2022.08.014_bib0033","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.expneurol.2015.08.018","article-title":"Microglia in the TBI brain: The good, the bad, and the dysregulated","volume":"275","author":"Loane","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0034","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","article-title":"Microglial activation in traumatic brain injury","volume":"9","author":"Donat","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12974-020-02005-x","article-title":"Cellular infiltration in traumatic brain injury","volume":"17","author":"Alam","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trsl.2022.08.014_bib0036","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1089\/neu.2015.4268","article-title":"Microglial\/macrophage polarization dynamics following traumatic brain injury","volume":"33","author":"Kumar","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148001","article-title":"Call off the Dog(ma): M1\/M2 polarization is concurrent following traumatic brain injury","volume":"11","author":"Morganti","year":"2016","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.trsl.2022.08.014_bib0038","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/cells11132091","article-title":"Microglia phenotypes in aging and neurodegenerative diseases","volume":"11","author":"Wendimu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2022.08.014_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5554824","article-title":"Microglia: a potential drug target for traumatic axonal injury","volume":"2021","author":"Huang","year":"2021","journal-title":"Neural Plast"},{"key":"10.1016\/j.trsl.2022.08.014_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fncel.2018.00306","article-title":"Switching of the microglial activation phenotype is a possible treatment for depression disorder","volume":"12","author":"Zhang","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0041","first-page":"22","article-title":"Glial-neuronal interactions in pathogenesis and treatment of spinal cord injury","author":"Lukacova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0042","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3389\/fimmu.2017.01520","article-title":"Molecular mechanisms modulating the phenotype of macrophages and microglia","volume":"8","author":"Amici","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0043","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1038\/s41598-022-10419-1","article-title":"Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations","volume":"12","author":"Gottlieb","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2022.08.014_bib0044","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/alz.12389","article-title":"Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease","volume":"18","author":"Boche","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.trsl.2022.08.014_bib0045","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/aps.2010.108","article-title":"Recent advances in (patho)physiology of astroglia","volume":"31","author":"Verkhratsky","year":"2010","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2022.08.014_bib0046","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2009.11.3\/mbelanger","article-title":"The role of astroglia in neuroprotection","volume":"11","author":"Belanger","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0047","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fncel.2018.00401","article-title":"Astrocyte heterogeneity in the adult central nervous system","volume":"12","author":"Miller","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0048","article-title":"Astrogliosis","volume":"7","author":"Sofroniew","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0049","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3390\/cells11121885","article-title":"Innate Immune Cell Death in Neuroinflammation and Alzheimer&rsquo;s disease","volume":"11","author":"Rajesh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2022.08.014_bib0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0051","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1083\/jcb.201602089","article-title":"The cell biology of inflammasomes: mechanisms of inflammasome activation and regulation","volume":"213","author":"Sharma","year":"2016","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0052","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1242\/jcs.207365","article-title":"Inflammasome activation and assembly at a glance","volume":"130","author":"Malik","year":"2017","journal-title":"J Cell Sci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0053","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","article-title":"Caspases in cell death, inflammation, and disease","volume":"50","author":"Van Opdenbosch","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2022.08.014_bib0054","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.cell.2021.11.011","article-title":"NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation","volume":"184","author":"Andreeva","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2022.08.014_bib0055","first-page":"371","article-title":"Human NLRP1 is a sensor for double-stranded RNA","author":"Bauernfried","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.08.014_bib0056","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/imr.12283","article-title":"The NLRP1 inflammasomes","volume":"265","author":"Chavarria-Smith","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2022.08.014_bib0057","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1042\/EBC20210021","article-title":"Inflammasome activation in neurodegenerative diseases","volume":"65","author":"Ravichandran","year":"2021","journal-title":"Essays Biochem"},{"key":"10.1016\/j.trsl.2022.08.014_bib0058","first-page":"228","article-title":"The neurometabolic cascade of concussion","volume":"36","author":"Giza","year":"2001","journal-title":"J Athl Train"},{"key":"10.1016\/j.trsl.2022.08.014_bib0059","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-020-01778-5","article-title":"The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target","volume":"17","author":"O'Brien","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trsl.2022.08.014_bib0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/imm.13336","article-title":"NLR family pyrin domain containing 3 (NLRP3) and caspase 1 (CASP1) modulation by intracellular Cl(-) concentration","volume":"163","author":"Clauzure","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2022.08.014_bib0061","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","article-title":"Caspases in cell death, inflammation, and pyroptosis","volume":"38","author":"Kesavardhana","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100924","article-title":"An overview of the non-canonical inflammasome","volume":"76","author":"Downs","year":"2020","journal-title":"Mol Aspects Med"},{"issue":"3","key":"10.1016\/j.trsl.2022.08.014_bib0063","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3390\/ijms22031048","article-title":"Advances in understanding activation and function of the NLRC4 inflammasome","volume":"22","author":"Sundaram","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0064","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41385-020-0256-z","article-title":"The NLRP6 inflammasome in health and disease","volume":"13","author":"Ghimire","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0065","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2018.09.047","article-title":"The NLRP6 inflammasome recognizes lipoteichoic acid and regulates gram-positive pathogen infection","volume":"175","author":"Hara","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2022.08.014_bib0066","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/jcbfm.2013.236","article-title":"Pyroptotic neuronal cell death mediated by the AIM2 inflammasome","volume":"34","author":"Adamczak","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"10.1016\/j.trsl.2022.08.014_bib0067","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1007\/s11033-020-05345-2","article-title":"Comprehensive review of ASC structure and function in immune homeostasis and disease","volume":"47","author":"Agrawal","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.trsl.2022.08.014_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.752482","article-title":"The ASC speck and NLRP3 inflammasome function are spatially and temporally distinct","volume":"12","author":"Nagar","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0069","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1096\/fj.201900439","article-title":"Inflammasome-mediated innateimmunity in Alzheimer's disease","volume":"33","author":"Venegas","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2022.08.014_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5631099","article-title":"Renal and inflammatory proteins as biomarkers of diabetic kidney disease and lupus nephritis","volume":"2022","author":"Johnson","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.trsl.2022.08.014_bib0071","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3390\/ph15060660","article-title":"Inflammatory biomarkers of traumatic brain injury","volume":"15","author":"Johnson","year":"2022","journal-title":"Pharmaceuticals (Basel)."},{"key":"10.1016\/j.trsl.2022.08.014_bib0072","article-title":"Netosis and inflammasomes in large vessel occlusion thrombi","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0073","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fneur.2018.00135","article-title":"Inflammasome proteins as biomarkers of multiple sclerosis","volume":"9","author":"Keane","year":"2018","journal-title":"Front Neurol."},{"key":"10.1016\/j.trsl.2022.08.014_bib0074","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","article-title":"Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets","volume":"17","author":"Govindarajan","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"13","key":"10.1016\/j.trsl.2022.08.014_bib0075","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.3390\/ijms21134674","article-title":"The inflammasome adaptor protein ASC in mild cognitive impairment and Alzheimer\u2019s disease","volume":"21","author":"Scott","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8100389","article-title":"Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions","volume":"8","author":"Jarrahi","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.trsl.2022.08.014_bib0077","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1227\/NEU.0000000000000505","article-title":"The new neurometabolic cascade of concussion","volume":"75","author":"Giza","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1016\/j.trsl.2022.08.014_bib0078","doi-asserted-by":"crossref","DOI":"10.1007\/s12975-022-01005-8","article-title":"Inflammasome-regulated pyroptotic cell death in disruption of the gut-brain axis after stroke","author":"Kerr","year":"2022","journal-title":"Transl Stroke Res"},{"issue":"51","key":"10.1016\/j.trsl.2022.08.014_bib0079","article-title":"The relation of subjective and objective assessment of sleep quality with post concussive symptoms in veterans","volume":"36","author":"Pollin","year":"2022","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2022.08.014_bib0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9478","article-title":"Association of traumatic brain injury with the risk of developing chronic cardiovascular, endocrine, neurological, and psychiatric disorders","volume":"5","author":"Izzy","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.trsl.2022.08.014_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113491","article-title":"Apolipoprotein E e4 is associated with worse self-reported neurobehavioral symptoms following uncomplicated mild traumatic brain injury in U.S. military service members","volume":"415","author":"Lange","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.trsl.2022.08.014_bib0082","doi-asserted-by":"crossref","first-page":"150","DOI":"10.15698\/cst2018.07.143","article-title":"Alzheimer's disease: amyloid-based pathogenesis and potential therapies","volume":"2","author":"Zhou","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.trsl.2022.08.014_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210128","article-title":"Inflammasome proteins as biomarkers of traumatic brain injury","volume":"13","author":"Kerr","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2022.08.014_bib0084","article-title":"Serum caspase-1 as an independent prognostic factor in traumatic brain injured patients","author":"Perez-Barcena","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.trsl.2022.08.014_bib0085","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3171\/2012.9.JNS12815","article-title":"Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article","volume":"117","author":"Adamczak","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.trsl.2022.08.014_bib0086","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3171\/2020.2.JNS193079","article-title":"Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome","volume":"134","author":"Perez-Barcena","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.trsl.2022.08.014_bib0087","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0041-1722817","article-title":"Cognitive retraining in traumatic brain injury: experience from tertiary care center in southern India","volume":"12","author":"Afsar","year":"2021","journal-title":"J Neurosci Rural Pract"},{"key":"10.1016\/j.trsl.2022.08.014_bib0088","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.0000000000005303","article-title":"Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies","volume":"90","author":"Arenaza-Urquijo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.trsl.2022.08.014_bib0089","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0090","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","article-title":"Common variants in Alzheimer's disease and risk stratification by polygenic risk scores","volume":"12","author":"de Rojas","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.08.014_bib0091","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0092","doi-asserted-by":"crossref","DOI":"10.1177\/17590914211051908","article-title":"Innate immunity and cell death in Alzheimer's disease","volume":"13","author":"Lee","year":"2021","journal-title":"ASN Neuro"},{"issue":"7","key":"10.1016\/j.trsl.2022.08.014_bib0093","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1007\/s12035-022-02863-x","article-title":"The amyloid precursor protein: a converging point in Alzheimer\u2019s disease","volume":"59","author":"Delport","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0094","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1523\/JNEUROSCI.1736-09.2009","article-title":"Beta-amyloid monomers are neuroprotective","volume":"29","author":"Giuffrida","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0096","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0097","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/alzrt217","article-title":"Autophagic\/lysosomal dysfunction in Alzheimer's disease","volume":"5","author":"Orr","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.trsl.2022.08.014_bib0098","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2022.08.014_bib0099","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/imr.12896","article-title":"The role of innate immunity in Alzheimer's disease","volume":"297","author":"Ennerfelt","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2022.08.014_bib0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.773590","article-title":"Microglia heterogeneity in Alzheimer's disease: insights from single-cell technologies","volume":"13","author":"Wang","year":"2021","journal-title":"Front Synaptic Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0101","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2022.08.014_bib0102","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fnagi.2019.00233","article-title":"Microglia in Alzheimer disease: well-known targets and new opportunities","volume":"11","author":"Hemonnot","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0103","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41593-021-00951-0","article-title":"Microglia contribute to the propagation of Abeta into unaffected brain tissue","volume":"25","author":"d'Errico","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0104","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","article-title":"beta-amyloid clustering around ASC fibrils boosts its toxicity in microglia","volume":"30","author":"Friker","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2022.08.014_bib0105","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.08.014_bib0106","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1742-2094-9-199","article-title":"Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-beta production in human neuron-like cells","volume":"9","author":"Sutinen","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trsl.2022.08.014_bib0107","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0108","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41418-021-00881-1","article-title":"Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment","volume":"29","author":"Flores","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.trsl.2022.08.014_bib0109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainresbull.2019.10.010","article-title":"Involvement of NLRC4 inflammasome through caspase-1 and IL-1beta augments neuroinflammation and contributes to memory impairment in an experimental model of Alzheimer's like disease","volume":"154","author":"Saadi","year":"2020","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.trsl.2022.08.014_bib0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0079-6123(06)61021-2","article-title":"Traumatic brain injury and Alzheimer's disease: a review","volume":"161","author":"Van Den Heuvel","year":"2007","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.trsl.2022.08.014_bib0111","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00415-021-10669-5","article-title":"Alzheimer's Disease Neuroimaging I. Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging","volume":"269","author":"Mohamed","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0112","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fimmu.2018.00672","article-title":"The inflammatory continuum of traumatic brain injury and alzheimer's disease","volume":"9","author":"Kokiko-Cochran","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0113","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1523\/JNEUROSCI.0858-11.2011","article-title":"Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities","volume":"31","author":"Tran","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.trsl.2022.08.014_bib0114","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2016.06.066","article-title":"Traumatic brain injury accelerates amyloid-beta deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease","volume":"629","author":"Shishido","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.trsl.2022.08.014_bib0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/neu.2015.3970","article-title":"Altered neuroinflammation and behavior after traumatic brain injury in a mouse model of Alzheimer's disease","volume":"33","author":"Kokiko-Cochran","year":"2016","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0116","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1089\/neu.2018.5982","article-title":"Age moderates the effects of traumatic brain injury on beta-amyloid plaque load in APP\/PS1 mice","volume":"36","author":"Collins","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0117","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1089\/neu.2021.0184","article-title":"Repetitive low-level blast exposure improves behavioral deficits and chronically lowers Abeta42 in an Alzheimer disease transgenic mouse model","volume":"38","author":"Perez Garcia","year":"2021","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0118","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3389\/fneur.2019.00980","article-title":"Tau pathology in chronic traumatic encephalopathy and Alzheimer's disease: similarities and differences","volume":"10","author":"Katsumoto","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0119","doi-asserted-by":"crossref","first-page":"e12239","DOI":"10.1002\/dad2.12239","article-title":"Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam-era veterans: a Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD-ADNI) study","volume":"13","author":"Clark","year":"2021","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.trsl.2022.08.014_bib0120","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fneur.2018.00978","article-title":"Microglia in Alzheimer's disease: risk factors and inflammation","volume":"9","author":"Katsumoto","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/neu.2018.6348","article-title":"Traumatic brain injury induces tau aggregation and spreading","volume":"37","author":"Edwards","year":"2020","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.trsl.2022.08.014_bib0122","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0123","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-020-01826-0","article-title":"IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis","volume":"17","author":"Desu","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.trsl.2022.08.014_bib0124","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-021-00467-w","article-title":"Metabolic regulation of pyroptotic cell death expands the therapeutic landscape for treating inflammatory disease","volume":"6","author":"Place","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.trsl.2022.08.014_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108595","article-title":"MCC950 in the treatment of NLRP3-mediated inflammatory diseases: latest evidence and therapeutic outcomes","volume":"106","author":"Bakhshi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0126","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1038\/s41467-020-18405-9","article-title":"Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging","volume":"11","author":"Flores","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.08.014_bib0127","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7879629","article-title":"VX765 attenuates pyroptosis and HMGB1\/TLR4\/NF-kappaB pathways to improve functional outcomes in TBI mice","volume":"2020","author":"Sun","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.trsl.2022.08.014_bib0128","unstructured":"Study of efficacy and safety of DV890 in patients with COVID-19 pneumonia. Available at: https:\/\/ClinicalTrials.gov\/show\/NCT04382053. Accessed June 2022."},{"key":"10.1016\/j.trsl.2022.08.014_bib0129","unstructured":"Study of efficacy and safety of MAS825 in patients with COVID-19.Available at: https:\/\/ClinicalTrials.gov\/show\/NCT04382651. Accessed June 2022."},{"key":"10.1016\/j.trsl.2022.08.014_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure","volume":"77","author":"Wohlford","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0131","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kluck","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.trsl.2022.08.014_bib0132","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imr.12908","article-title":"Therapeutic modulation of inflammasome pathways","volume":"297","author":"Chauhan","year":"2020","journal-title":"Immunol Rev"},{"key":"10.1016\/j.trsl.2022.08.014_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111442","article-title":"Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease","volume":"138","author":"Chen","year":"2021","journal-title":"Biomed Pharmacother"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422002018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422002018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:47:48Z","timestamp":1761828468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524422002018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":133,"alternative-id":["S1931524422002018"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2022.08.014","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammasome activation in traumatic brain injury and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2022.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}